Existing investor syndicate supports atrial shunting as effective therapy for heart failure patients TEWKSBURY, Mass., June 9, 2022 /PRNewswire/ — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced the closing of a $54 million equity financing from its existing investor syndicate. Funds will be utilized to […]
Financial
Heartfelt Dreams Foundation Announces The Launch Of Advanced Cardiology Fellows Grant For 2022
Nonprofit dedicated to advancing treatment and education for congenital heart defects will award a $5,000 Grant to a deserving hospital-based advanced cardiology fellow Hollis, NH (December 13, 2021) – Heartfelt Dreams Foundation, a nonprofit organization dedicated to enhancing the treatment experience for congenital heart defect (CHD) patients and their families […]
Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension
MLS-101 is a Highly Selective Aldosterone Synthase Inhibitor Designed to Address Abnormally Elevated Aldosterone, an Underlying Cause of Hypertension Prevalent in a Significant Portion of Patients Derek DiRocco of RA Capital Management and Olivier Litzka, PhD of Andera Partners Join Mineralys Board of Directors PHILADELPHIA, June 8, 2022 /PRNewswire/ — Mineralys Therapeutics, Inc., a private, […]
CorVista Health Announces Drs. Vallerie V. McLaughlin and Mark G. Rabbat Join Medical Advisory Board
WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the expansion of their Medical Advisory Board with the appointment of Drs. Vallerie V. McLaughlin and Mark G. Rabbat. The expansion of the Medical Advisory Board reflects the company’s focus on pulmonary hypertension, coronary artery disease […]
SANUWAVE Business Update
Estimated May Revenue Increase of 96% Year Over Year Sales Funnel Increases 5% and System Trials Increases 2% Month Over Month SUWANEE, GA, June 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — On June 7, 2022, SANUWAVE Health, Inc. (OTC: PINK: SNWV), a leading provider of next-generation wound care products, provided an […]
Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business
— Company Expects to Achieve Approximately $100 Million in Cost Savings Over the Next 12 Months* While Continuing to Invest in European Launches and Global Expansion — — Reduces U.S. Commercial Organization by Ninety Percent of Pre-Pandemic / Pre-Generic Competition Levels — — Creates Core Focused U.S. Commercial Team to […]
Amarin Appoints Tom Reilly as New Chief Financial Officer
— Experienced Executive Brings More Than Twenty Years of Global Financial Leadership to Amarin — — Michael W. Kalb to Depart Amarin to Pursue Other Interests — DUBLIN, Ireland and BRIDGEWATER, N.J., June 06, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Tom Reilly as […]
Broadview Ventures Promotes Maria Berkman to Managing Director of Longview Ventures
Boston, Massachusetts, June 1, 2022 Broadview Ventures, a mission-driven investment firm dedicated to accelerating the development of promising technology for the diagnosis and treatment of cardiovascular disease and stroke, today announces the promotion of Maria Berkman to Managing Director of Longview Ventures. Longview Ventures is an independent investment vehicle that makes […]
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CARLSBAD, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on June 1, 2022 that were approved by the Compensation Committee of its Board of […]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on May 31, 2022 it granted stock options to purchase an aggregate of 179,100 shares of common stock to 23 new employees, whose employment commenced in May 2022, as a material inducement to […]



